Please login to the form below

Hamell secures two behaviour change wins

LONDON, UK – Revolutionary behaviour change healthcare communications agency, Hamell, has been awarded two ground-breaking new projects.

Fiona Hammond, Managing Director at Hamell, commented, “Changing behaviour is our business and we are pleased that the value of what we do is achieving further recognition. We have been working in this field for over 7 years, putting us at the forefront of what is an area of growing interest in the healthcare communications industry.”

Behavioural segmentation

The first of the new wins will involve the roll out of a large-scale behavioural segmentation project across the UK and Europe.Fiona Hammond commented, “At Hamell, we passionately believe that it’s impossible to achieve sustained behaviour change unless we understand why people behave the way they do. For us, this means that behavioural segmentation of our target population – prescribers, patients, OTC consumers and payers – is essential. 

“Behavioural segmentation involves identifying theoretically sound and statistically significant differentiation between groups on the basis of their behavioural drivers – what makes them the type of people they are and therefore behave the way they do. This allows us to segment customers into behavioural types, making it possible to understand and change behaviour and improve communication around a brand by developing segment-specific messages delivered through their preferred channels. We’re excited to be applying our expertise to this new piece of work.”

Nudging for public health

The second new project will see Hamell ‘Nudging’ across Europe to promote a brand that has the potential to positively impact public health.

Working in collaboration with external experts from Cambridge University, Columbia Business School and the UK Government’s behavioural unit, Hamell will identify, create and evaluate nudges and other behavioural change strategies to increase uptake, targeting customers and HCPs at all stages of the patient journey.

Fiona added, “This is a significant piece of behavioural work with potential to feed into a whole new approach to marketing the brand and bring about important improvements in public health across Europe. We are honoured to have been selected for this worthwhile project.”

About Hamell

Hamell is no ordinary healthcare communications agency. Their focus is on understanding and changing behaviour. The company has evolved since launching in 2008, now offering a complete360˚ service from behavioural research through to the delivery of both traditional and non-traditional promotional initiatives and creative campaigns.

Hamell works with some of the UK’s leading behavioural academics and every project passes through the hands of expert advisors. Everything they do springboards from robust behavioural findings, enabling them to transform HCP prescribing, patient adherence or OTC purchasing.

Hamell’s creative solutions target the core drivers of behaviour to bring about lasting behaviour change.

Please visit to find out more.

Fiona Hammond
1a Salcott Road
SW11 6DQ

11th August 2015



Company Details


020 7978 5206

Contact Website

1st Floor
Dome Building
The Quadrant

Latest content on this profile

Unfinished Plans featured in Daily Mail as actor urges young people struggling with thoughts of suicide to speak out
Oliver Devoti, who appeared in Unfinished Plans, created in partnership with PAPYRUS as part of the ‘Creativity for Good’ Campaign, shares his very personal story of how suicide has impacted his life and urges young people to seek help.
Hamell selected by PM Society's 'Creativity for Good' initiative
Hamell have been selected by the PM Society’s charity partner PAPYRUS Prevention of Young Suicide, to develop a fundraising campaign as part of their 'Creativity for Good' initiative
Marc Greener joins Hamell as their Creative Director, reuniting with Frank Walters
Marc Greener has joined behaviour-led communications experts Hamell.
Hamell recognised at British Medical Association (BMA) awards for excellence in patient information
Three booklets from Boehringer Ingelheim’s More than Scleroderma campaign have been commended by the world-renowned BMA for excellence in patient information.
Making good practice common practice in rare disease

Hamell celebrate creativity! Orrin Pollard selected as juror at the 2017 Cannes Lions Festival of Creativity